Microbial intracellular DNA and proteins

Microbial intracellular DNA and proteins represent a broad category of molecular targets within bacteria, protozoa, and fungi that are susceptible to damage by reactive antimicrobial agents (DrugBank). This target profile is primarily associated with the mechanism of action of nitroimidazole and nitrofuran antibiotics, which undergo intracellular reduction to form reactive intermediates that cause DNA strand breakage and enzymatic inhibition (DrugBank; PubMed). Additionally, antimicrobial nanoparticles (e.g., silver, copper, and tellurium) and reactive oxygen species (ROS) target these components by inducing oxidative stress, leading to protein denaturation and genomic instability (Iraqi Journal of Nanotechnology, 2023; RSC, 2025; MDPI, 2025). By targeting multiple essential cellular components simultaneously, these agents can bypass specific resistance mechanisms and maintain efficacy against a wide range of anaerobic and microaerophilic organisms (NIH, 2025). However, the non-specific nature of these interactions poses therapeutic challenges, as potential genotoxic or oxidative damage to host cells must be minimized through selective activation or localized delivery (StatPearls). This "target" is essentially a collective term for the intracellular sites of action for drugs that rely on the generation of non-specific reactive species rather than binding to a single, defined protein pocket (PubMed).

Other names

Bacterial DNA and proteinsMicrobial nucleic acids and proteinsIntracellular microbial componentsMicrobial genomic DNA and cellular proteins

Intracellular reduction to reactive intermediates that cause non-specific oxidative damage, covalent binding, and strand breakage in microbial DNA and proteins (DrugBank; PubMed).